Published in J Clin Oncol on November 01, 1987
Combination therapy with irinotecan and cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer. Br J Cancer (1999) 1.06
Promising treatment results of adjuvant chemotherapy following radical hysterectomy for intermediate risk stage 1B cervical cancer. Obstet Gynecol Sci (2013) 0.93
Stretching the Limits of Laparoscopy in Gynecological Oncology: Technical Feasibility of doing a Laparoscopic Total Pelvic Exenteration for Palliation in advanced Cervical Cancer. Int J Biomed Sci (2009) 0.84
The Globalization of Cooperative Groups. Semin Oncol (2015) 0.82
Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med (1995) 7.83
Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med (1996) 5.56
Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin (1982) 4.90
Evaluation of cancer information on the Internet. Cancer (1999) 4.55
The effect of an individual's cytochrome CYP3A4 activity on docetaxel clearance. Clin Cancer Res (2000) 2.14
Effects of a physician communication intervention on patient care outcomes. J Gen Intern Med (1996) 2.06
Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer (1978) 2.04
Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study. J Clin Oncol (1998) 1.91
Comparison of continuously infused 5-fluorouracil with bolus injection in treatment of patients with colorectal adenocarcinoma. Cancer (1975) 1.84
Left ventricular mass in the elderly. The Cardiovascular Health Study. Hypertension (1997) 1.59
Retinal microvascular abnormalities and blood pressure in older people: the Cardiovascular Health Study. Br J Ophthalmol (2002) 1.58
Dose response evaluation of adriamycin in human neoplasia. Cancer (1977) 1.51
Reactivity to alcohol-related cues: physiological and subjective responses in alcoholics and nonproblem drinkers. J Stud Alcohol (1985) 1.50
Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients. J Pharm Sci (1989) 1.48
Role of DTIC (NSC-45388) in the chemotherapy of sarcomas. Cancer Treat Rep (1976) 1.45
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study. Leukemia (2010) 1.42
Phase II evaluation of adriamycin in human neoplasia. Cancer (1973) 1.40
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group study. J Natl Cancer Inst (1991) 1.40
Pharmacokinetics of 5-fluorouracil administered orally, by rapid intravenous and by slow infusion. Cancer Res (1980) 1.38
Utility of new electrocardiographic models for left ventricular mass in older adults. The Cardiovascular Health Study Collaborative Research Group. Hypertension (1996) 1.37
Laparoscopically assisted surgical staging (LASS) of endometrial cancer. Gynecol Oncol (1993) 1.31
In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet (1980) 1.30
Characterization of a new human endometrial carcinoma (RL95-2) established in tissue culture. In Vitro (1983) 1.29
Chemotherapy of malignant fibrous histiocytoma: a Southwest Oncology Group report. Cancer (1977) 1.27
Improved therapeutic index of carboplatin plus cyclophosphamide versus cisplatin plus cyclophosphamide: final report by the Southwest Oncology Group of a phase III randomized trial in stages III and IV ovarian cancer. J Clin Oncol (1992) 1.26
Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide. Cancer (1972) 1.18
Transabdominal cerclage: a laparoscopic approach. Obstet Gynecol (1998) 1.17
Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol (1998) 1.17
4-Hydroxylation of estradiol by human uterine myometrium and myoma microsomes: implications for the mechanism of uterine tumorigenesis. Proc Natl Acad Sci U S A (1995) 1.15
Meigs syndrome and elevated CA 125. Obstet Gynecol (1989) 1.14
Serum levels of interleukins, growth factors and angiogenin in patients with endometrial cancer. J Cancer Res Clin Oncol (1997) 1.12
Laparoscopic para-aortic lymphadenectomy in gynecologic malignancies. Obstet Gynecol (1993) 1.09
Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study. J Clin Oncol (1987) 1.08
Early influence of popliteal vein repair in the treatment of popliteal vessel injuries. Am J Surg (1971) 1.08
Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest (1998) 1.07
Combined laparoscopic and vaginal surgery for the management of two cases of stage I endometrial cancer. Gynecol Oncol (1992) 1.06
Ifosfamide. J Natl Cancer Inst (1988) 1.03
Abdominal-wall tumor implantation after laparoscopy for malignant conditions. Obstet Gynecol (1994) 1.00
Cognitive changes after alcohol cue exposure. J Consult Clin Psychol (1987) 1.00
Laparoscopic surgical staging of ovarian cancer. Gynecol Oncol (1995) 0.99
Is the P388 murine tumor no longer adequate as a drug discovery model? Invest New Drugs (1987) 0.99
The role of laparoscopic lymphadenectomy in the management of cervical carcinoma. Gynecol Oncol (1992) 0.99
Acquired hypertrichosis languiginosa. Report of two new cases and a review of the literature. Cancer (1975) 0.98
Pharmacologic studies of anticancer drugs with the human tumor stem cell assay. Cancer Chemother Pharmacol (1981) 0.98
Tamoxifen therapy in recurrent epithelial ovarian carcinoma. Gynecol Oncol (1987) 0.97
More on reliability of death certificates. N Engl J Med (1981) 0.96
Comparison of the long-term, postsurgical survival of women and men in the Coronary Artery Surgery Study (CASS). Am Heart J (1989) 0.95
Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study. J Clin Oncol (1984) 0.94
The natural history of metastatic synovial sarcoma: experience of the Southwest Oncology group. Clin Orthop Relat Res (1982) 0.94
Laparoscopic staging of the patient with incompletely staged early adenocarcinoma of the endometrium. Obstet Gynecol (1994) 0.94
Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study. Cancer (1976) 0.93
Double-blind crossover study of the antiemetic efficacy of high-dose dexamethasone versus high-dose metoclopramide. J Clin Oncol (1984) 0.93
A Southwest Oncology Group study on the use of a human tumor cloning assay for predicting response in patients with ovarian cancer. Cancer (1991) 0.92
Follow-up comparison of hydrocephalus with and without myelomeningocele. J Neurosurg (1975) 0.92
Mitomycin-C, bleomycin, vincristine, and cis-platinum in the treatment of advanced, recurrent squamous cell carcinoma of the cervix. Cancer Clin Trials (1981) 0.92
Adriamycin and 5-fluorouracil in the treatment of advanced hepatoma: a Southwest Oncology Group study. Cancer Treat Rep (1977) 0.91
Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results. J Nucl Med (1999) 0.91
Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep (1980) 0.90
Activity of isotretinoin against squamous cell cancers and preneoplastic lesions. Cancer Treat Rep (1982) 0.90
Uterine leiomyosarcoma. Am J Obstet Gynecol (1979) 0.90
Laparoscopic management of suspicious adnexal masses. Am J Obstet Gynecol (1996) 0.90
Tumor angiogenesis as a predictor of recurrence in stage Ib squamous cell carcinoma of the cervix. Obstet Gynecol (1996) 0.90
Mitomycin C, vincristine, and bleomycin therapy for advanced cervical cancer. Obstet Gynecol (1978) 0.90
Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer. Cancer Treat Rep (1976) 0.90
Predictors of perceived health status in elderly men and women. The Cardiovascular Health Study. J Aging Health (1994) 0.90
Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. Cancer Chemother Pharmacol (1989) 0.90
Immediate termination of intractable vomiting induced by cisplatin combination chemotherapy using an intensive five-drug antiemetic regimen. Cancer Treat Rep (1984) 0.89
Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study. J Clin Oncol (1990) 0.89
Malignant pelvic lymphoma. Am J Obstet Gynecol (1982) 0.89
Progress in screening for early breast cancer. J Surg Oncol (1985) 0.89
Laparoscopy using the left upper quadrant as the primary trocar site. Gynecol Oncol (1993) 0.88
Epidemiological findings in a brain-tumor cluster in western Missouri. J Neurosurg (1985) 0.88
Epithelial ovarian neoplasms of low malignant potential. Gynecol Oncol (1985) 0.88
Phase I evaluation and clinical pharmacology of tricyclic nucleoside 5'-phosphate using a weekly intravenous regimen. Cancer Res (1986) 0.88
Case report: topical DMSO for mitomycin-C-induced skin ulceration. Oncol Nurs Forum (1991) 0.87
Proceedings: Evaluation of combination vs. sequential cytotoxic chemotherapy in the treatment of advanced breast cancer. Cancer (1974) 0.87
Evaluation of combination chemotherapy and phase II agents in pancreatic adenocarcinoma. A Southwest Oncology Group study. Cancer (1993) 0.87
A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma. Cancer (1990) 0.87
Tumor board in gynecologic oncology. Int J Gynecol Cancer (2004) 0.87
Stroke in coronary artery bypass graft surgery: an analysis of the CASS experience. The participants in the Coronary Artery Surgery Study. Int J Cardiol (1992) 0.86
Intraepithelial carcinoma of the cervix associated with pregnancy. Obstet Gynecol (1972) 0.86
Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613). J Clin Oncol (1987) 0.86
Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma. Cancer Treat Rep (1981) 0.86
Phase I and II evaluation of cytembena in disseminated epithelial ovarian cancers and sarcomas. Cancer Treat Rep (1976) 0.85
Cone biopsy during pregnancy. Obstet Gynecol (1982) 0.85
Adenoid cystic carcinoma of the Cervix. Report of 9 cases and a reappraisal. Obstet Gynecol (1978) 0.85
The relationship of herpesvirus to carcinoma of the prostate. J Urol (1981) 0.85
A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer. Cancer (1991) 0.85
Long-term survival with metastatic uterine sarcoma. N Y State J Med (1985) 0.84
Second-line treatment of advanced measurable ovarian cancer with iproplatin: a Southwest Oncology Group study. Eur J Cancer (1991) 0.84
A 10-year review of primary fallopian tube cancer at a community hospital: a high association of synchronous and metachronous cancers. Int J Gynecol Cancer (2006) 0.84
Adjuvant chemotherapy in early uterine sarcoma. Gynecol Oncol (1983) 0.84
The use of fluoroscopy to guide needle placement in interstitial gynecological brachytherapy. Int J Radiat Oncol Biol Phys (1998) 0.84
13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial. Gynecol Oncol (1998) 0.83